Reproductive Toxicology

SJR Rank #6,812H-index: 139SJR: 0.808Best quartile: Q2APC: US$3,800
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • ToxicologyQ2

Areas: Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Effects and risks of endocrine disrupting chemicalsBirth, Development, and HealthToxic Organic Pollutants ImpactReproductive Biology and FertilitySperm and Testicular FunctionPregnancy and Medication ImpactCarcinogens and Genotoxicity AssessmentPregnancy and preeclampsia studiesHeavy Metal Exposure and ToxicityEstrogen and related hormone effects

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025060120180240

Detailed Information

ISSN

0890-6238, 1873-1708

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

3.71

References per Document

62.23

Coverage

1987-2026

Scope

Drawing from a large number of disciplines, Reproductive Toxicology publishes timely, original research on the influence of chemical and physical agents on reproduction. Written by and for obstetricians, pediatricians, embryologists, teratologists, geneticists, toxicologists, andrologists, and others interested in detecting potential reproductive hazards, the journal is a forum for communication among researchers and practitioners. Articles focus on the application of in vitro, animal and clinical research to the practice of clinical medicine. All aspects of reproduction are within the scope of Reproductive Toxicology, including the formation and maturation of male and female gametes, sexual function, the events surrounding the fusion of gametes and the development of the fertilized ovum, nourishment and transport of the conceptus within the genital tract, implantation, embryogenesis, intrauterine growth, placentation and placental function, parturition, lactation and neonatal survival. Adverse reproductive effects in males will be considered as significant as adverse effects occurring in females. To provide a balanced presentation of approaches, equal emphasis will be given to clinical and animal or in vitro work. Typical end points that will be studied by contributors include infertility, sexual dysfunction, spontaneous abortion, malformations, abnormal histogenesis, stillbirth, intrauterine growth retardation, prematurity, behavioral abnormalities, and perinatal mortality.

Metrics from SCImago Journal Rank 2025. View on SCImago